Editorial standards
How we write these
Anyone can sound certain about peptides. These are the rules every Newport Peptide Society guide is written to, so a reader can judge the work rather than take our word for it.
- 01
Every claim carries its source
A number, a date, or a finding in a guide points to a numbered reference the reader can pull: a journal article, a prescribing label, an FDA document, a court record, or a company release. Where the only source is a vendor's listing, the guide says so and treats it as a description of what is sold, not as evidence.
- 02
Animal findings and human findings are never mixed
A rat study is reported as a rat study. A human case series is reported with its size, its design, and whether anyone was blinded. When the human record is three small uncontrolled reports, the guide says three small uncontrolled reports, not 'clinical evidence.'
- 03
Trial results name their product and their population
A weight-loss figure from a trial of an approved injector is not transferred to a compounded vial or a research-chemical powder. A result in people with HIV, or with a rare disease, is not transferred to healthy adults. The guide names who was studied and with what.
- 04
Doses are reported, not recommended
Each catalog title carries a standard dosing block: the vial size as sold, the water added, the resulting concentration, and a table of the protocol as a label, a clinic, or a seller states it, with the draw in milliliters and in units on a U-100 syringe. A dose is never given in units without its concentration. The block exists so a reader can check arithmetic against a label, and it says whose protocol it is and whether any study supports it.
- 05
Regulatory status is dated and specific
Approved, compoundable, under review, and prohibited are different things, and the guides keep them apart: which list, which category, which date, which vote, and what the vote did or did not change. Every status statement is current as of the edition date printed on the cover, and changes are logged.
- 06
What is sold is described as sold
Titles use the names vendors use, including blend vials, because that is what a reader is holding. Describing a product is not endorsing it. Each guide states plainly when a product has no approval, no pharmacy pathway, no human study, or no verified contents.
- 07
The strongest honest sentence, not the strongest sentence
No superlatives, no borrowed enthusiasm from sellers, and no reflexive alarm either. When a drug works, the guide says what the trial measured and by how much. When nothing has been measured, it says that. Each guide ends with what does have evidence for the problem the product is sold for.
- 08
Editions are fixed; the web keeps moving
A printed guide is the edition on its cover. The web version of every catalog title carries a dated Latest section of developments since that edition, each with a source, and a public log of every correction. A body fact that turns out wrong is fixed in the body and recorded in the log, not quietly overwritten.
Who writes, and who has not reviewed
The guides are researched and written by the Society’s editors from primary sources, and checked against those sources before an edition prints. No physician or pharmacist has yet reviewed an edition. When one has, that reviewer’s name and credentials will appear on the title, and this page will say so. Until then, the references are the review: every one is listed so a clinician can check the work.
We publish guides. We do not sell, prescribe, recommend, or supply any peptide, and no vendor pays for placement or mention. Nothing in a guide is medical advice.
Corrections
If a guide states something wrong, write to us with the reference. Corrections are made in the guide and recorded, with the date and what changed, on the What changed page.